In the present study, we established in vitro and in vivo models of chronic liver injury and evaluated the possible mechanism involved in the ability of DIM to alleviate CCl4-induced liver fibrosis in mice and TGF-β1 mediated EMT in AML12 cells. This evidence concerns the gene TGFB1 and Hepatic fibrosis.